Share on StockTwits

USANA Health Sciences Inc. (NASDAQ:USNA) issued an update on its FY14 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $5.50-5.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.66, AnalystRatings.Net reports. The company issued revenue guidance of $770-790 million, compared to the consensus revenue estimate of $784.99 million.

USANA Health Sciences Inc. (NASDAQ:USNA) traded down 1.51% on Tuesday, hitting $68.59. 191,113 shares of the company’s stock traded hands. USANA Health Sciences Inc. has a 1-year low of $55.01 and a 1-year high of $92.00. The stock’s 50-day moving average is $75.65 and its 200-day moving average is $72.36. The company has a market cap of $954.9 million and a P/E ratio of 12.83.

USANA Health Sciences (NASDAQ:USNA) last announced its earnings results on Tuesday, July 29th. The company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.50 by $0.14. The company had revenue of $188.30 million for the quarter, compared to the consensus estimate of $198.30 million. During the same quarter in the previous year, the company posted $1.72 earnings per share. The company’s revenue for the quarter was down .4% on a year-over-year basis. On average, analysts predict that USANA Health Sciences Inc. will post $5.66 earnings per share for the current fiscal year.

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.